
Q&A with Christian John Lillis, CEO and Co-Founder of the Peggy Lillis Foundation
OpenDialog July 2026 – Issue Three This month’s Q&A features the CEO and Co-Founder of the Peggy Lillis Foundation (PLF), the leading nonprofit organization that is building a nationwide C. diff (Clostridioides difficile) awareness movement by educating the public, empowering advocates, and shaping policy. He is Christian John Lillis, a tireless advocate, fundraiser and thought […]

Q&A with Dr. Alexander Khoruts, Director of the Microbiota Therapeutics Program, UMN
OpenDialog May 2026 – Issue Two Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations in Q&A format with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. No jargon, no fluff. Just […]

Q&A with Christian John Lillis, CEO and Co-Founder of the Peggy Lillis Foundation
OpenDialog July 2026 – Issue Three
This month’s Q&A features the CEO and Co-Founder of the Peggy Lillis Foundation (PLF), the leading nonprofit organization that is building a nationwide C. diff (Clostridioides difficile) awareness movement by educating the public, empowering advocates, and shaping policy. He is Christian John Lillis, a tireless advocate, fundraiser and thought leader; and most critically, Christian is the eldest son of Peggy Lillis who died tragically at the age of 56 from C. diff.


Q&A with Dr. Cliff McDonald, CDC
OpenDialog March 2026 – Issue One

Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. The first edition features Dr. L. Clifford McDonald, MD, Associate Director for Science in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC), one of the foremost experts in Clostridioides difficile (C. difficile) epidemiology.

Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey
STAT Feature Article: By Eric Boodman
March 23, 2026
Advancing Care for Pediatric Patients with C. difficile: Insights from a Clinical Webinar on Investigational FMT
OpenBiome convened a live webinar featuring a distinguished panel of physicians from Boston Children’s Hospital, Texas Children’s Hospital, and the University of Minnesota. The discussion focused on the clinical management of pediatric patients with Clostridioides difficile (C. difficile) infection, with a particular emphasis on diagnostic considerations and the use of investigational fecal microbiota transplantation (FMT).

Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study
Studies of the microbes living on and in our bodies are conducted mainly in a few rich countries, squandering opportunities to improve the health of people globally.

STAT OpEd: Fecal transplants are saving lives — but are now at risk
By Neil Stollman, MD
Stollman is chief of the Division of Gastroenterology at the Alta Bates Summit Medical Center and works at the East Bay Center for Digestive Health, both in Oakland, California.
Twenty years ago, a respected colleague asked me to perform a “poop transplant” on a local schoolteacher with multiply recurrent C. difficile infection. I was incredulous and skeptical, but my colleague (a friend but a forceful one) persisted until I ultimately acquiesced.
Policy Outlook: Building a microbiome-informed approach to agri-food systems and childhood nutrition policies
A holistic, microbiome-informed approach to agrifood systems and childhood nutrition policies—rooted in global collaboration, evidence-building, and equitable innovation—can drive sustainable solutions to undernutrition and improve children’s health worldwide.

Boosting microbiome science worldwide could save millions of children’s lives

OpenBiome Foundation Launches to Catalyze Breakthroughs in Microbiome Science

Science in the Field: Dr. Walter Sandoval’s Mission to Map Rural Microbiomes in Paraguay

Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis.

From Stool Donation to FMT Preparation: The Logistics of FMT Manufacturing

When is an FMT Treatment Ready for Use? Health Monitoring and Material Release

Tracking Patient Outcomes and Adverse Events: Considerations for Pharmacovigilance

Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection















